Sonoporation is the transient permeability of cell membranes caused by ultrasound. Large scale oscillation of nearby microbubbles (MB) is considered to be the primary effect in sonoporation whereas inertial cavitation is associated with increased cell damage. MB behavior and therefore therapy success strongly depend on acoustic excitation parameters. We introduce a robust method to identify an adequate working point for effective sonoporation therapy despite unknown tissue attenuation. The presented algorithm identifies the inertial cavitation threshold of a MB cloud by correlating double pulse echoes. Its performance is demonstrated in simulations of the dynamic behavior of SonoVue MBs in a sound field and verified by measurements in a setup with acoustical and optical observation of the MBs. Sonoporation therapy of monolayers of SW480 cells in this setup reveals that the pressure amplitude just below inertial cavitation generates the highest sonoporation rate. This algorithm is further implemented on an image guided small animal sonoporation therapy system and a phantom with varying attenuation (0.1-4 dB. The inertial cavitation threshold is correctly identified with an RMSE of 0.14 dB). The proposed method allows safe, effective and reproducible MB therapy in in vitro and in vivo applications without time consuming calibration or reference measurements.
Introduction
Sonoporation is the transient permeability of cell membranes caused by ultrasound. It is increased by the presence of microbubbles (MBs) in ultrasound contrast agents and has been shown to improve targeted drug delivery and gene therapy significantly [1, 2] . Large scale oscillation of nearby microbubbles is considered to be the primary effect in sonoporation whereas inertial cavitation at high ultrasound pressure amplitudes is associated with increased cell damage [3] [4] [5] . MB oscillation just below the inertial cavitation threshold promises successful therapy results with a large sonoporation rate and low numbers of dead cells. Since MB behavior and therefore therapy success strongly depend on the ultrasound excitation, it is crucial to control the acoustic parameters at the therapy site. For an in vitro setup, calibration measurements and time consuming reference experiments may reveal the optimal acoustic excitation. But especially when it comes to in vivo therapy applications, pressure amplitudes at the therapy site often differ from calibration measurements. The propagating sound wave is affected by tissue attenuation and constructive wave interferences at reflecting interfaces [6] . Furthermore, therapy sessions often include sound exposures at several positions, resulting in varying sound paths during one session. Thus, safe and reproducible therapy is difficult without the knowledge of the pressure amplitudes or rather MB behavior at the therapy site. There are several approaches to evaluate MB behavior in a sound field by the analysis of harmonics in the echoes or coded excitation sequences. Many of these methods only provide reliable information about MB behavior with a sufficient signal-to-noise-ratio in optimized setups or for single bubble conditions [7, 8] . A robust method for MB cloud interrogation in in vitro and in vivo applications with sufficient signal-to-noise-ratio is the detection of MB destruction by the analysis of the correlation of consecutive pulses [9] . With varying pressure amplitudes, the violent destruction of MBs and thus the threshold for inertial cavitation can be determined. This method is independent of attenuating tissue or constructive wave interference in the sound path. In this paper a robust algorithm is presented that identifies the inertial cavitation threshold of a MB cloud. This is demonstrated by simulations and by measurements in a setup with acoustical and optical observations of the MB behavior. Sonoporation therapy of cell monolayers enclosed in the setup reveals the pressure amplitude just below inertial cavitation threshold as an adequate working point for effective and safe therapy. The robustness of the algorithm, which is implemented on an image guided small animal sonoporation therapy system and tested with a phantom, is also verified for changes of attenuation in the sound path.
Methods
The algorithm correlates the echoes of two identical five cycle sine-bursts. If MBs are destructed by the first burst (e 1 ) due to inertial cavitation, the echo from the second burst (e 2 ) differs from the first. This is quantified by dividing the maximum of the normalized cross-correlation by the maximum of the first burst's autocorrelation [9] : For low amplitudes, no MBs are destructed: both echoes correlate and equals 1. For high pressure amplitudes, MBs suffer from inertial cavitation and is reduced. Thus, increasing the burst amplitude, the threshold to inertial cavitation can be determined.
In a first step, the bursts' echoes for varying amplitudes are simulated using established models for dynamic MB behavior and destruction. The model presented by Marmottant et al. [10] is based on the (modified) Rayleigh-Plesset equation and is used to compute the MB's dynamic behavior when driven by a five cycle sine burst. If the MB's radius is compressed below one tenth of its maximal radius , the shell becomes unstable and inertial cavitation occurs [9, 11] :
This criterion is used to define the destruction of an oscillating MB. The MB's radiated sound in distance is then computed by [11] , (2.3)
with the liquid density and the bubble radius . With this model, the echo of a SonoVue® (Bracco, Milano, Italy) MB cloud is simulated by considering size distribution and material properties [12] . Simulations are verified in a setup for acoustic and optical observation of MB behavior during sonoporation as described in detail in [1] and displayed in Fig. 1 . SonoVue® MBs (0.3 ml) and growth medium (9.6 ml Dulbecco's Modified Eagle Medium, Invitrogen, Life Technologies, Carlsbad, USA) are filled in an OptiCell TM container (BioCrystal Ltd., Westerville, OH, USA) with optical and acoustical transparent membranes. Sound bursts are emitted by a therapy transducer (H101, Sonic Concepts, Bothell, USA) at 3.3 MHz. The MBs in the container are placed in the transducer's focus. Pressure amplitudes in the transducer's focus were measured by a calibrated needle hydrophone (0.2 mm needle diameter, SN 273, Precision Acoustics, Dorchester, UK) and range from 75 to 750 kPa. Scattered signals are received by a broadband detection transducer (C380, Olympus NDT, Waltham, USA) and recorded by a digitizer card (CompuScope 12400, GaGe, Lockport, USA). This procedure is optically observed by a microscope (LV-DIA, Nikon, Tokyo, Japan). Thus, MB destruction is detected optically and acoustically.
To reveal the excitation amplitude just below inertial cavitation threshold as an adequate working point, monolayers of SW480 cells (human colon adenocarcinoma) are grown in each container. The detection of the temporal poration of a cell membrane (sonoporation) is provided by adding 0.1 ml of propidium iodide (PI) (1 mg/ml, Sigma Aldrich, St. Louis, USA) to the growth medium. PI cannot overcome intact cell membranes and changes its fluorescence properties when bound to intracellular fluid. The temporal poration therefore creates a sharp rise of fluorescence intensity and a subsequent decrease, which is monitored with the microscope [1] . Dead cells can be identified by an ongoing increase in fluorescence intensity to a plateau. For statistically significant results, double bursts were emitted 50 times in one therapy session. Each session was repeated three times for each pressure amplitude.
The algorithm is then implemented on a small animal sonoporation therapy device, which consists of a custom designed 1 MHz ring transducer (Imasonic, Voray-surl'Ognon, France) with a central opening for the imaging transducer of a programmable diagnostic ultrasound machine (L14-5/38, SonixTouch, Ultrasonix, Richmond, Canada). A water filled housing with a sound transparent membrane (thickness 0.025 mm, Goodfellow Cambridge Ltd., Huntingdon, UK) couples the sound into the object by gel. The imaging transducer serves for image guidance and as a detection transducer for therapy echoes. For sonoporation therapy, a flow phantom consisting of a channel in a polystyrene slide (μ-Slide upright, Ibidi, Martinsried, Germany) in a tissue mimicking polyvinyl alcohol (PVA) phantom is used. To evaluate the algorithm's performance despite varying attenuation, five layers made from PVA are placed in the sound path between membrane and phantom. The attenuation of each layer was measured by the hydrophone and ranges from 0.1 to 4 dB at 1 MHz. The setup is shown in Fig. 2. 3 Results Simulations reveal the correlation of the two echos equal to 1 for low pressure amplitudes (Fig. 3) . With MBs suffering from inertial cavitation (at 0.5 MPa), this coefficient is reduced. A shifted exponential decay can be fitted to the simulation values by minimizing the squared error. This way the threshold of inertial cavitation is determined to be at 0.47 MPa. According to these simulations, the algorithm is able to identify the inertial cavitation threshold. These results are verified by measurements in the observation setup. The onset of MB destruction can be observed acoustically (Fig. 4) . Hydrophone calibration measurements and the fitted exponential curve determines the threshold for inertial cavitation to be at 0.45 MPa. The evaluation of fluorescence images reveal an increase of the sonoporation rate for increasing burst amplitude.
The maximum is reached at 0.43 MPa, which is just below the threshold for inertial cavitation at 0.45 MPa (Fig. 4) . For higher amplitudes, the sonoporation rate decreases due to an increased number of dead cells. This reveals the pressure amplitude just below inertial cavitation to be an adequate working point for sonoporation therapy.
The overall low sonoporation rate with the maximum of 1.9 % is owing to the design of the setup, which was optimized for optical observation of MB cell interaction.
Higher in vitro sonoporation rates can be expected from therapy in cell suspensions [2] .
The exponential decay of echo decorrelation is further verified by the small animal sonoporation setup and flow phantom. The inertial cavitation threshold is determined by calibration measurements to be at 0.46 MPa (Fig. 5 ). This value is reproduced despite the different attenuation layers in the sound path with a RMSE of 0.14 MPa. Fig. 6 shows the determined values for the different attenuation layers. For increasing attenuation, precision and accuracy of threshold detection increase. Thus, the method determines the inertial cavitation threshold despite varying attenuation in the sound path. These results show that the pressure amplitude just below the inertial cavitation threshold is an adequate working point for high sonoporation rate. The working point can be determined by a robust method despite unknown tissue attenuation or constructive wave interference.
Conclusion
The performance of an algorithm was presented, that reveals an adequate working point for safe and effective sonoporation therapy. By determining the inertial cavitation threshold of injected MBs, reproducible therapy is possible despite changes in the sound path. With this algorithm, save MB therapy is possible without time consuming calibration measurements and reference experiments.
